Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mice are treated with FIDAS-5 (20 mg/kg) for 1 week
A Phase II study of intravenous exatecan administered daily for 5 days
Mirtazapine is an atypical antidepressant with noradrenergic and specific serotonergic activity
1946833-85-7 (citrate)
20)21)22-11-14-5-4-6-15(10-14)25-3/h4-11H
PF-06463922 5109 HCl Mice are treated with FIDAS-5Lorlatinib, also known as PF 06463922, is an orally available, ATP competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C ros oncogene 1 (Ros1), with potential antineoplastic activity. Upon administration, ALK ROS1 inhibitor PF 06463922 binds to and inhibits both ALK and ROS1 kinases. The kinase inhibition leads to disruption of ALK and ROS1 mediated signaling and eventually inhibits tumor cell growth in ALK and
US$ 274.50
US$ 18.00
US$ 139.30
US$ 399.00
US$ 240.80
US$ 254.80
US$ 159.60
US$ 183.00
US$ 1374.00
US$ 1185.50
US$ 173.60
US$ 138.60